195 related articles for article (PubMed ID: 38782986)
1. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges.
Warner BM; Yates JGE; Vendramelli R; Truong T; Meilleur C; Chan L; Leacy A; Pham PH; Pei Y; Susta L; Wootton SK; Kobasa D
NPJ Vaccines; 2024 May; 9(1):90. PubMed ID: 38782986
[TBL] [Abstract][Full Text] [Related]
2. Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.
González-Domínguez I; Martínez JL; Slamanig S; Lemus N; Liu Y; Lai TY; Carreño JM; Singh G; Singh G; Schotsaert M; Mena I; McCroskery S; Coughlan L; Krammer F; García-Sastre A; Palese P; Sun W
Microbiol Spectr; 2022 Jun; 10(3):e0153822. PubMed ID: 35658571
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with Ad5-based vaccines protects Syrian hamsters from challenge with omicron and delta variants of SARS-CoV-2.
Braun MR; Martinez CI; Dora EG; Showalter LJ; Mercedes AR; Tucker SN
Front Immunol; 2023; 14():1086035. PubMed ID: 36911687
[TBL] [Abstract][Full Text] [Related]
4. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.
Warner BM; Santry LA; Leacy A; Chan M; Pham PH; Vendramelli R; Pei Y; Tailor N; Valcourt E; Leung A; He S; Griffin BD; Audet J; Willman M; Tierney K; Albietz A; Frost KL; Yates JGE; Mould RC; Chan L; Mehrani Y; Knapp JP; Minott JA; Banadyga L; Safronetz D; Wood H; Booth S; Major PP; Bridle BW; Susta L; Kobasa D; Wootton SK
iScience; 2021 Nov; 24(11):103219. PubMed ID: 34632328
[TBL] [Abstract][Full Text] [Related]
5. Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization.
Zhang QY; Zhang HQ; Zhang YN; Zhang ZR; Li XD; Hao MC; Zhang Y; Li JQ; Hu YY; Chen XL; Wang J; Shi YJ; Deng CL; Chen JJ; Ye HQ; Zhang B
Antiviral Res; 2023 Dec; 220():105757. PubMed ID: 37984567
[TBL] [Abstract][Full Text] [Related]
6. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice.
Slamanig S; González-Domínguez I; Chang LA; Lemus N; Lai TY; Martínez JL; Singh G; Dolange V; Abdeljawad A; Kowdle S; Noureddine M; Warang P; Singh G; Lee B; García-Sastre A; Krammer F; Schotsaert M; Palese P; Sun W
EBioMedicine; 2024 Jun; 105():105185. PubMed ID: 38848648
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of an adenovirus-vectored bivalent vaccine against wild type SARS-CoV-2 and Omicron variants in a murine model.
Ji Y; Sui X; Miao W; Wang C; Wang Q; Duan Z; Wei B; Wu D; Wei M; Shao J; Zheng X; Zhu T
Vaccine; 2024 Feb; 42(6):1292-1299. PubMed ID: 38296705
[TBL] [Abstract][Full Text] [Related]
8. Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats.
Tcheou J; Raskin A; Singh G; Kawabata H; Bielak D; Sun W; González-Domínguez I; Sather DN; García-Sastre A; Palese P; Krammer F; Carreño JM
Front Immunol; 2021; 12():791764. PubMed ID: 34868082
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.
Beavis AC; Li Z; Briggs K; Huertas-Díaz MC; Wrobel ER; Najera M; An D; Orr-Burks N; Murray J; Patil P; Huang J; Mousa J; Hao L; Hsiang TY; Gale M; Harvey SB; Tompkins SM; Hogan RJ; Lafontaine ER; Jin H; He B
bioRxiv; 2022 Jun; ():. PubMed ID: 35702147
[TBL] [Abstract][Full Text] [Related]
10. A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern.
Xu J; Zhang Y; Qu P; Shamseldin MM; Yoo SJ; Misny J; Thongpan I; Kc M; Hall JM; Evans JP; Eltobgy M; Lu M; Ye C; Chamblee M; Liang X; Martinez-Sobrido L; Amer AO; Yount JS; Boyaka PN; Peeples ME; Liu SL; Dubey P; Li J
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2220403120. PubMed ID: 37796985
[TBL] [Abstract][Full Text] [Related]
11. Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.
González-Domínguez I; Martínez JL; Slamanig S; Lemus N; Liu Y; Lai TY; Carreño JM; Singh A G; Singh B G; Schotsaert M; Mena I; McCroskery S; Coughlan L; Krammer F; García-Sastre A; Palese P; Sun W
bioRxiv; 2022 Mar; ():. PubMed ID: 35350201
[TBL] [Abstract][Full Text] [Related]
12. Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques.
Warner BM; Chan M; Tailor N; Vendramelli R; Audet J; Meilleur C; Truong T; Garnett L; Willman M; Soule G; Tierney K; Albietz A; Moffat E; Higgins R; Santry LA; Leacy A; Pham PH; Yates JGE; Pei Y; Safronetz D; Strong JE; Susta L; Embury-Hyatt C; Wootton SK; Kobasa D
Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675786
[TBL] [Abstract][Full Text] [Related]
13. Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection.
Kim DH; Lee J; Youk S; Jeong JH; Lee DY; Ju HS; Youn HN; Kim JC; Park SB; Park JE; Kim JY; Kim TH; Lee SH; Lee H; Mouhamed Abdallah Amal Abdal L; Lee DH; Park PG; Hong KJ; Song CS
Vaccine; 2023 Jul; 41(33):4787-4797. PubMed ID: 37355454
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
Hsieh M-S; Hsu C-W; Liao H-C; Lin C-L; Chiang C-Y; Chen M-Y; Liu S-J; Liao C-L; Chen H-W
J Virol; 2024 Feb; 98(2):e0154623. PubMed ID: 38299865
[TBL] [Abstract][Full Text] [Related]
15. Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.
Díaz MF; Calderón K; Rojas-Neyra A; Vakharia VN; Choque-Guevara R; Montalvan-Avalos A; Poma-Acevedo A; Rios-Matos D; Agurto-Arteaga A; Cauti-Mendoza MG; Perez-Martinez N; Isasi-Rivas G; Tataje-Lavanda L; Sernaque-Aguilar Y; Ygnacio F; Criollo-Orozco M; Huaccachi-Gonzalez E; Delgado-Ccancce E; Villanueva-Pérez D; Montesinos-Millán R; Gutiérrez-Manchay K; Pauyac-Antezana K; Ramirez-Ortiz I; Quiñones-Garcia S; Cauna-Orocollo Y; Vallejos-Sánchez K; Rios-Angulo A; Núñez-Fernández D; Salguedo-Bohorquez MI; Ticona J; Fernández-Sánchez M; Icochea E; Guevara-Sarmiento LA; Zimic M;
Sci Rep; 2022 Jun; 12(1):10359. PubMed ID: 35725862
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2.
Park JG; Oladunni FS; Rohaim MA; Whittingham-Dowd J; Tollitt J; Hodges MDJ; Fathallah N; Assas MB; Alhazmi W; Almilaibary A; Iqbal M; Chang P; Escalona R; Shivanna V; Torrelles JB; Worthington JJ; Jackson-Jones LH; Martinez-Sobrido L; Munir M
iScience; 2021 Sep; 24(9):102941. PubMed ID: 34368648
[TBL] [Abstract][Full Text] [Related]
18. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.
van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP
Front Immunol; 2021; 12():781280. PubMed ID: 34987509
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of a chimpanzee adenovirus vector expressing a pre-fusion spike (BV-AdCoV-1) protects golden Syrian hamsters against SARS-CoV-2 infection.
Wang S; Xu L; Mu T; Qin M; Zhao P; Xie L; Du L; Wu Y; Legrand N; Mouchain K; Fichet G; Liu Y; Yin W; Zhao J; Ji M; Gong B; Klein M; Wu K
Front Cell Infect Microbiol; 2022; 12():979641. PubMed ID: 36405962
[TBL] [Abstract][Full Text] [Related]
20. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Vesin B; Lopez J; Noirat A; Authié P; Fert I; Le Chevalier F; Moncoq F; Nemirov K; Blanc C; Planchais C; Mouquet H; Guinet F; Hardy D; Vives FL; Gerke C; Anna F; Bourgine M; Majlessi L; Charneau P
Mol Ther; 2022 Sep; 30(9):2984-2997. PubMed ID: 35484842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
